164 related articles for article (PubMed ID: 9378698)
1. The atypical antipsychotic sertindole: a case series.
Lee AM; Knoll JL; Suppes T
J Clin Psychiatry; 1997 Sep; 58(9):410-6; quiz 417-8. PubMed ID: 9378698
[TBL] [Abstract][Full Text] [Related]
2. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.
Azorin JM; Murteira S; Hansen K; Toumi M
BMC Psychiatry; 2008 Mar; 8():16. PubMed ID: 18366634
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
Pezawas L; Quiner S; Moertl D; Tauscher J; Barnas C; Küfferle B; Wolf R; Kasper S
Int Clin Psychopharmacol; 2000 Jul; 15(4):207-14. PubMed ID: 10954060
[TBL] [Abstract][Full Text] [Related]
5. Sertindole for the treatment of schizophrenia.
Azorin JM; Kaladjian A; Fakra E; Adida M
Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
Azorin JM; Strub N; Loft H
Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole--a 123I IBZM single photon emission tomography (SPET) study.
Pilowsky LS; O'Connell P; Davies N; Busatto GF; Costa DC; Murray RM; Ell PJ; Kerwin RW
Psychopharmacology (Berl); 1997 Mar; 130(2):152-8. PubMed ID: 9106913
[TBL] [Abstract][Full Text] [Related]
8. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
Perquin L; Steinert T
CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
[TBL] [Abstract][Full Text] [Related]
9. Sertindole : a review of its use in schizophrenia.
Murdoch D; Keating GM
CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
[TBL] [Abstract][Full Text] [Related]
10. A case of treatment-refractory psychosis responsive to sertindole.
Geracioti TD; Parker S; Lowther NB; Wortman M; Richtand NM
Schizophr Res; 1998 Feb; 30(1):105-8. PubMed ID: 9542794
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
12. Emerging treatments in the management of schizophrenia - focus on sertindole.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Settineri S; Zoccali R
Drug Des Devel Ther; 2010 Sep; 4():187-201. PubMed ID: 20856845
[TBL] [Abstract][Full Text] [Related]
13. Sertindole in schizophrenia: efficacy and safety issues.
Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
[TBL] [Abstract][Full Text] [Related]
14. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
16. Drug safety and efficacy evaluation of sertindole for schizophrenia.
Karamatskos E; Lambert M; Mulert C; Naber D
Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
[TBL] [Abstract][Full Text] [Related]
17. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
18. [The experience of using the atypical antipsychotic sertindole in psychiatric inpatient clinics in Russia].
Ivanets NN; Kinkul'kina MA; Avdeeva TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):37-41. PubMed ID: 21716249
[TBL] [Abstract][Full Text] [Related]
19. A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.
van Kammen DP; McEvoy JP; Targum SD; Kardatzke D; Sebree TB
Psychopharmacology (Berl); 1996 Mar; 124(1-2):168-75. PubMed ID: 8935813
[TBL] [Abstract][Full Text] [Related]
20. Case histories illustrating the utility of sertindole in clinical practice.
Schuck P; van den Ameele H; Jaanson P; Ryckmans V; Hawley C
CNS Drugs; 2004; 18 Suppl 2():31-40; discussion 41-3. PubMed ID: 15461314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
